封面
市場調查報告書
商品編碼
1713587

2025年全球遺傳基因檢測市場報告

Hereditary Genetic Testing Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年遺傳基因檢測的市場規模將快速成長。到 2029 年,這一數字將成長至 362.3 億美元,複合年成長率為 11.0%。預測期內的成長歸因於癌症盛行率的增加、遺傳病患病率的增加、診斷需求的增加、個人化醫療的採用增加以及臨床試驗數量的增加。預測期內的主要趨勢包括技術進步、全基因定序、基因資料整合、個人化醫療和非侵入性產前檢測。

預計未來幾年癌症盛行率的上升將推動遺傳基因檢測市場的成長。癌症包括一組以細胞異常生長為特徵並可擴散至身體其他部位的疾病。癌症患者比例的增加與人口老化、生活方式的改變、接觸環境污染物、遺傳易感性和診斷方法的進步等因素有關。遺傳基因檢測在癌症預防中發揮重要作用,它可以識別增加癌症風險的基因突變,並促進早期監測和有針對性的預防活動。例如,根據澳洲健康與福利研究所(政府機構)的數據,澳洲確診的癌症病例數預計將從 2021 年的 156,781 例增加到 2022 年的 160,570 例,較去年與前一年同期比較成長。因此,癌症盛行率的不斷上升刺激了遺傳基因檢測市場的擴張。

遺傳基因檢測產業的主要企業正專注於開發尖端基因組解決方案,例如多癌症多基因面板,以改善早期檢測並提供個人化的治療方案。這些多基因面板可檢測多種癌症的多種基因變異,支持早期診斷和客製化治療策略。例如,2024 年 2 月,美國癌症篩檢和診斷測試提供者 Exact Sciences Corporation 宣布推出 Riskguard 遺傳性癌症測試。該測試使用簡單的血液或唾液樣本,針對 10 種常見癌症類型提供基因特異性和遺傳性癌症風險的個人化報告。它可以幫助患者了解自己的癌症風險,為篩檢和治療決策提供資訊,並評估與家庭相關的癌症風險。此外,識別可操作的基因變異可以幫助癌症患者制定個人化治療方案,並改善有癌症家族病史患者的風險評估。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球基因檢測PESTEL分析(政治、社會、技術、環境、法律因素、促進因素與限制因素)
  • 最終用途產業分析
  • 全球遺傳基因檢測市場:成長率分析
  • 全球遺傳基因檢測市場表現:規模與成長,2019-2024
  • 全球遺傳基因檢測市場預測:規模與成長,2024-2029 年,2034 年
  • 全球基因基因檢測總目標市場(TAM)

第6章市場區隔

  • 全球基因檢測市場類型、績效及預測(2019-2024 年、2024-2029 年及 2034 年)
  • 預測性和症狀前檢測
  • 職業測試
  • 產前和新生兒檢測
  • 診斷測試
  • 藥物基因組學檢測
  • 其他類型
  • 全球遺傳基因檢測市場(依技術、績效及預測),2019-2024 年、2024-2029 年、2034 年
  • 細胞遺傳學檢測
  • 生物化學檢驗
  • 分子檢測
  • 全球基因檢測市場(依臨床應用、績效及預測),2019-2024 年、2024-2029 年、2034 年
  • 癌症基因檢測
  • 心血管基因檢測
  • 神經系統基因檢測
  • 罕見疾病基因檢測
  • 全球基因檢測市場(按最終用戶、績效和預測)2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 診斷實驗室
  • 研究組織
  • 直接面對消費者(DTC)基因檢測公司
  • 全球遺傳基因檢測市場,按類型細分,預測和徵兆測試,績效和預測,2019-2024 年,2024-2029 年,2034 年
  • 基因檢測用於疾病風險預測
  • 遺傳性癌症風險檢測
  • 心血管疾病風險測試
  • 神經退化性疾病風險測試
  • 全球遺傳基因檢測市場依載體檢測類型細分,實際狀況及預測,2019-2024 年、2024-2029 年、2034 年
  • 遺傳疾病檢測
  • 體染色體隱性遺傳疾病的基因檢測
  • 檢測遺傳疾病的帶因者狀態
  • 全球基因檢測市場,依產前及新生兒檢測類型細分,績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 非侵入性產前檢測(NIPT)
  • 羊膜穿刺術和絨毛膜絨毛絨毛採樣(CVS)
  • 新生兒篩檢
  • 懷孕前基因篩檢
  • 全球基因檢測市場按診斷檢測類型、效能和預測細分,2019-2024 年、2024-2029 年、2034 年
  • 基因檢測以確認疑似遺傳疾病
  • 檢測遺傳綜合症和先天性疾病
  • 癌症診斷測試​​和腫瘤分析
  • 全球基因檢測市場,依藥物基因體學檢測類型細分,績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 藥物反應和療效的基因檢測
  • 藥物敏感性和副作用測試
  • 個人化醫療和治療最佳化
  • 全球基因基因檢測市場及其他細分市場,依類型、實際規模及預測,2019-2024 年、2024-2029 年、2034 年
  • 健康和生活方式基因檢測
  • 血統和家譜基因檢測
  • 研究驅動的基因檢測

第7章 區域和國家分析

  • 全球基因檢測市場:按地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球基因檢測市場:依國家、績效及預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章競爭格局與公司概況

  • 遺傳基因檢測市場:競爭格局
  • 遺傳基因檢測市場:公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Quest Diagnostics Incorporated
  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Hologic Inc.
  • Illumina Inc.
  • Qiagen NV
  • Exact Sciences Corporation
  • Fulgent Genetics Inc.
  • BioReference Laboratories Inc.
  • BGI Group
  • Invitae Corporation
  • NeoGenomics Laboratories Inc.
  • andMe Inc.
  • MyHeritage Ltd.
  • Color Health Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年遺傳基因檢測市場:提供新機會的國家
  • 2029年基因基因檢測市場:細分領域帶來新機會
  • 2029年基因檢測市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33489

Hereditary genetic testing is a medical procedure that analyzes deoxyribonucleic acid (DNA) to detect inherited gene mutations that may lead to disease. It helps assess an individual's risk of developing certain genetic conditions passed down from parents to offspring. This type of testing is commonly used for conditions such as cancer, heart disease, and rare inherited disorders.

The primary types of hereditary genetic testing include predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and others. Predictive and presymptomatic testing identifies individuals at risk of developing specific diseases before symptoms manifest. The technologies used for testing include cytogenetic testing, biochemical testing, and molecular testing. Clinical applications encompass genetic testing for cancer, cardiovascular conditions, neurological disorders, and rare diseases. End users include hospitals and clinics, diagnostic laboratories, research institutes, and direct-to-consumer (DTC) genetic testing companies.

The hereditary genetic testing market research report is one of a series of new reports from The Business Research Company that provides hereditary genetic testing market statistics, including hereditary genetic testing industry global market size, regional shares, competitors with a hereditary genetic testing market share, detailed hereditary genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary genetic testing industry. This hereditary genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hereditary genetic testing market size has grown rapidly in recent years. It will grow from $21.47 billion in 2024 to $23.88 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to a rise in the incidence of inherited disease, growth in healthcare informatics, growth in telemedicine, growth in awareness campaigns, and a rising number of genetic testing platforms.

The hereditary genetic testing market size is expected to see rapid growth in the next few years. It will grow to $36.23 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising prevalence of genetic disorders, rising demand for diagnostics, increasing adoption of personalized medicine, and rising number of clinical trials. Major trends in the forecast period include technological advancements, whole-genome sequencing, integration of genetic data, personalized medicine, and non-invasive prenatal testing.

The rising prevalence of cancer is expected to drive the growth of the hereditary genetic testing market in the coming years. Cancer encompasses a group of diseases characterized by abnormal cell growth that can spread to other areas of the body. The increasing rate of cancer cases is linked to factors such as aging populations, lifestyle changes, exposure to environmental pollutants, genetic predispositions, and advancements in diagnostic methods. Hereditary genetic testing plays a key role in cancer prevention by identifying genetic mutations that increase cancer risk, facilitating early monitoring and targeted prevention efforts. For example, according to the Australian Institute of Health and Welfare, a government agency, the number of cancer cases diagnosed in Australia rose from 156,781 in 2021 to 160,570 in 2022, highlighting a year-over-year increase. Consequently, the growing prevalence of cancer is fueling the expansion of the hereditary genetic testing market.

Leading companies in the hereditary genetic testing industry are focusing on developing cutting-edge genomic solutions, such as multi-cancer multigene panels, to improve early detection and provide personalized treatment options. These multigene panels test for multiple genetic mutations across various cancers, supporting early diagnosis and customized treatment strategies. For instance, in February 2024, Exact Sciences Corporation, a U.S.-based provider of cancer screening and diagnostic tests, introduced the Riskguard hereditary cancer test. This test offers a personalized report on gene-specific and familial cancer risks using a simple blood or saliva sample for 10 common cancers. It helps patients understand their cancer risk, informs screening and treatment decisions, and assesses family-related cancer risks. Additionally, it aids in tailoring treatment for cancer patients and improving risk assessment for individuals with a family history of cancer by identifying actionable gene variants.

In January 2022, Exact Sciences Corp., a U.S.-based molecular diagnostics company, acquired PreventionGenetics for an undisclosed sum. This acquisition was intended to enhance Exact Sciences Corp.'s portfolio of advanced cancer diagnostics and support its entry into hereditary cancer testing. PreventionGenetics is a U.S.-based genetic testing laboratory.

Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Amgen Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, NeoGenomics Laboratories Inc., 23andMe Inc., MyHeritage Ltd., Color Health Inc., MedGenome Inc., SOPHiA GENETICS SA, Devyser AB, Mapmygenome India Ltd., Igenomix S.L.

North America was the largest region in the hereditary genetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hereditary genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hereditary genetic testing market includes revenues earned by entities by providing services such as carrier screening, prenatal testing, and newborn screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hereditary Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hereditary genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hereditary genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hereditary genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Predictive And Presymptomatic Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing; Other Types
  • 2) By Technology: Cytogenetic Testing; Biochemical Testing; Molecular Testing
  • 3) By Clinical Application: Cancer Genetic Testing; Cardiovascular Genetic Testing; Neurological Genetic Testing; Rare Diseases Genetic Testing
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Direct To Consumer (DTC) Genetic Testing Companies
  • Subsegments:
  • 1) By Predictive and Presymptomatic Testing: Genetic Testing For Disease Risk Prediction; Testing For Inherited Cancer Risks; Cardiovascular Disease Risk Testing; Neurodegenerative Disease Risk Testing
  • 2) By Carrier Testing: Testing For Inherited Genetic Disorders; Genetic Screening For Autosomal Recessive Diseases; Testing For Carrier Status Of Inherited Conditions
  • 3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Amniocentesis and Chorionic Villus Sampling (CVS); Newborn Screening For Genetic Disorders; Preconception Genetic Screening
  • 4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders; Testing For Inherited Syndromes and Congenital Diseases; Diagnostic Testing For Cancer and Tumor Profiling
  • 5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy; Testing For Drug Sensitivities and Side Effects; Personalized Medicine and Treatment Optimization
  • 6) By Other Types: Genetic Testing For Wellness And Lifestyle; Genetic Testing For Ancestry And Genealogy; Research-Oriented Genetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Amgen Inc.; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hereditary Genetic Testing Market Characteristics

3. Hereditary Genetic Testing Market Trends And Strategies

4. Hereditary Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hereditary Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hereditary Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hereditary Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Hereditary Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hereditary Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hereditary Genetic Testing Total Addressable Market (TAM)

6. Hereditary Genetic Testing Market Segmentation

  • 6.1. Global Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive And Presymptomatic Testing
  • Carrier Testing
  • Prenatal And Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Other Types
  • 6.2. Global Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cytogenetic Testing
  • Biochemical Testing
  • Molecular Testing
  • 6.3. Global Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Genetic Testing
  • Cardiovascular Genetic Testing
  • Neurological Genetic Testing
  • Rare Diseases Genetic Testing
  • 6.4. Global Hereditary Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Direct To Consumer (DTC) Genetic Testing Companies
  • 6.5. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Predictive and Presymptomatic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing For Disease Risk Prediction
  • Testing For Inherited Cancer Risks
  • Cardiovascular Disease Risk Testing
  • Neurodegenerative Disease Risk Testing
  • 6.6. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Testing For Inherited Genetic Disorders
  • Genetic Screening For Autosomal Recessive Diseases
  • Testing For Carrier Status Of Inherited Conditions
  • 6.7. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Prenatal and Newborn Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive Prenatal Testing (NIPT)
  • Amniocentesis and Chorionic Villus Sampling (CVS)
  • Newborn Screening For Genetic Disorders
  • Preconception Genetic Screening
  • 6.8. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing For Confirming Suspected Genetic Disorders
  • Testing For Inherited Syndromes and Congenital Diseases
  • Diagnostic Testing For Cancer and Tumor Profiling
  • 6.9. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing For Drug Response And Efficacy
  • Testing For Drug Sensitivities and Side Effects
  • Personalized Medicine and Treatment Optimization
  • 6.10. Global Hereditary Genetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing For Wellness And Lifestyle
  • Genetic Testing For Ancestry And Genealogy
  • Research-Oriented Genetic Testing

7. Hereditary Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Hereditary Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hereditary Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hereditary Genetic Testing Market

  • 8.1. Asia-Pacific Hereditary Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hereditary Genetic Testing Market

  • 9.1. China Hereditary Genetic Testing Market Overview
  • 9.2. China Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hereditary Genetic Testing Market

  • 10.1. India Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hereditary Genetic Testing Market

  • 11.1. Japan Hereditary Genetic Testing Market Overview
  • 11.2. Japan Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hereditary Genetic Testing Market

  • 12.1. Australia Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hereditary Genetic Testing Market

  • 13.1. Indonesia Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hereditary Genetic Testing Market

  • 14.1. South Korea Hereditary Genetic Testing Market Overview
  • 14.2. South Korea Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hereditary Genetic Testing Market

  • 15.1. Western Europe Hereditary Genetic Testing Market Overview
  • 15.2. Western Europe Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hereditary Genetic Testing Market

  • 16.1. UK Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hereditary Genetic Testing Market

  • 17.1. Germany Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hereditary Genetic Testing Market

  • 18.1. France Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hereditary Genetic Testing Market

  • 19.1. Italy Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hereditary Genetic Testing Market

  • 20.1. Spain Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hereditary Genetic Testing Market

  • 21.1. Eastern Europe Hereditary Genetic Testing Market Overview
  • 21.2. Eastern Europe Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hereditary Genetic Testing Market

  • 22.1. Russia Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hereditary Genetic Testing Market

  • 23.1. North America Hereditary Genetic Testing Market Overview
  • 23.2. North America Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hereditary Genetic Testing Market

  • 24.1. USA Hereditary Genetic Testing Market Overview
  • 24.2. USA Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hereditary Genetic Testing Market

  • 25.1. Canada Hereditary Genetic Testing Market Overview
  • 25.2. Canada Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hereditary Genetic Testing Market

  • 26.1. South America Hereditary Genetic Testing Market Overview
  • 26.2. South America Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hereditary Genetic Testing Market

  • 27.1. Brazil Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hereditary Genetic Testing Market

  • 28.1. Middle East Hereditary Genetic Testing Market Overview
  • 28.2. Middle East Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hereditary Genetic Testing Market

  • 29.1. Africa Hereditary Genetic Testing Market Overview
  • 29.2. Africa Hereditary Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hereditary Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hereditary Genetic Testing Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hereditary Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Hereditary Genetic Testing Market Competitive Landscape
  • 30.2. Hereditary Genetic Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

31. Hereditary Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Quest Diagnostics Incorporated
  • 31.2. Eurofins Scientific SE
  • 31.3. Agilent Technologies Inc.
  • 31.4. Hologic Inc.
  • 31.5. Illumina Inc.
  • 31.6. Qiagen N.V.
  • 31.7. Exact Sciences Corporation
  • 31.8. Fulgent Genetics Inc.
  • 31.9. BioReference Laboratories Inc.
  • 31.10. BGI Group
  • 31.11. Invitae Corporation
  • 31.12. NeoGenomics Laboratories Inc.
  • 31.13.23andMe Inc.
  • 31.14. MyHeritage Ltd.
  • 31.15. Color Health Inc.

32. Global Hereditary Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hereditary Genetic Testing Market

34. Recent Developments In The Hereditary Genetic Testing Market

35. Hereditary Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Hereditary Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hereditary Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hereditary Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33489_Hereditary_Genetic_Testing_GMR_2025